Oh J, Vidal-Jordana A, Montalban X. Multiple sclerosis: clinical aspects. Curr Opin Neurol. 2018;31:752–9. https://doi.org/10.1097/WCO.0000000000000622.

Article  PubMed  Google Scholar 

Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17:162–73. https://doi.org/10.1016/S1474-4422(17)30470-2.

Article  PubMed  Google Scholar 

Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014;83:278–86. https://doi.org/10.1212/WNL.0000000000000560.

Article  PubMed  PubMed Central  Google Scholar 

Kuhlmann T, Moccia M, Coetzee T, Cohen JA, Correale J, Graves J, et al. Multiple sclerosis progression: time for a new mechanism-driven framework. Lancet Neurol. 2023;22:78–88. https://doi.org/10.1016/S1474-4422(22)00289-7.

Article  PubMed  Google Scholar 

Pitt D, Lo CH, Gauthier SA, Hickman RA, Longbrake E, Airas LM, et al. Toward Precision Phenotyping of Multiple Sclerosis. Neurol Neuroimmunol Neuroinflammation Wolters Kluwer. 2022;9:e200025. https://doi.org/10.1212/NXI.0000000000200025.

Article  Google Scholar 

Tunç A, Seferoğlu M, Sıvacı AÖ, Köktürk MD, Akbaş AA, Bozkurt B, et al. Oligoclonal band count as a marker of disease activity and progression in multiple sclerosis: A multicenter study. J Clin Neurosci. 2024;126:353–60. https://doi.org/10.1016/j.jocn.2024.07.013.

Article  CAS  PubMed  Google Scholar 

Calvi A, Tur C, Chard D, Stutters J, Ciccarelli O, Cortese R, et al. Slowly expanding lesions relate to persisting black-holes and clinical outcomes in relapse-onset multiple sclerosis. NeuroImage Clin. 2022;35:103048. https://doi.org/10.1016/j.nicl.2022.103048.

Article  PubMed  PubMed Central  Google Scholar 

Maranzano J, Dadar M, Rudko DA, De Nigris D, Elliott C, Gati JS, et al. Comparison of Multiple Sclerosis Cortical Lesion Types Detected by Multicontrast 3T and 7T MRI. Am J Neuroradiol. 2019;40:1162–9. https://doi.org/10.3174/ajnr.A6099.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kappos L, Wolinsky JS, Giovannoni G, Arnold DL, Wang Q, Bernasconi C, et al. Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials. JAMA Neurol. 2020;77:1132–40. https://doi.org/10.1001/jamaneurol.2020.1568.

Article  PubMed  PubMed Central  Google Scholar 

Okuda DT, Mowry EM, Beheshtian A, Waubant E, Baranzini SE, Goodin DS, et al. Incidental MRI anomalies suggestive of multiple sclerosis: The radiologically isolated syndrome. Neurology. 2009;72:800–5. https://doi.org/10.1212/01.wnl.0000335764.14513.1a.

Article  CAS  PubMed  Google Scholar 

Lebrun-Frenay C, Kantarci O, Siva A, Sormani MP, Pelletier D, Okuda DT, et al. Radiologically Isolated Syndrome: 10-Year Risk Estimate of a Clinical Event. Ann Neurol. 2020;88:407–17. https://doi.org/10.1002/ana.25799.

Article  CAS  PubMed  Google Scholar 

Makhani N, Tremlett H. The multiple sclerosis prodrome. Nat Rev Neurol. 2021;17:515–21. https://doi.org/10.1038/s41582-021-00519-3.

Article  PubMed  PubMed Central  Google Scholar 

Montalban X, Lebrun-Frénay C, Oh J, Arrambide G, Moccia M, Pia Amato M, et al. Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria. Lancet Neurol. 2025;24:850–65. https://doi.org/10.1016/S1474-4422(25)00270-4.

Article  PubMed  Google Scholar 

Filippi M, Bar-Or A, Piehl F, Preziosa P, Solari A, Vukusic S, et al. Multiple sclerosis. Nat Rev Dis Primer. Nat Rev Dis Primers. 2018;4. https://doi.org/10.1038/S41572-018-0041-4.

Adams CWM. The onset and progression of the lesion in multiple sclerosis. J Neurol Sci Elsevier. 1975;25:165–82. https://doi.org/10.1016/0022-510X(75)90138-0.

Article  CAS  Google Scholar 

Barnett MH, Prineas JW. Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion. Ann Neurol. Volume 55. Wiley, Ltd;; 2004. pp. 458–68. https://doi.org/10.1002/ANA.20016.

Kalincik T, Buzzard K, Jokubaitis V, Trojano M, Duquette P, Izquierdo G, et al. Risk of relapse phenotype recurrence in multiple sclerosis. Mult Scler J SAGE Publications Ltd STM. 2014;20:1511–22. https://doi.org/10.1177/1352458514528762.

Article  Google Scholar 

Mowry EM, Deen S, Malikova I, Pelletier J, Bacchetti P, Waubant E. The onset location of multiple sclerosis predicts the location of subsequent relapses. J Neurol Neurosurg Psychiatry. 2009;80:400–3. https://doi.org/10.1136/jnnp.2008.157305.

Article  CAS  PubMed  Google Scholar 

Deen S, Bacchetti P, High A, Waubant E. Predictors of the location of multiple sclerosis relapse. J Neurol Neurosurg Psychiatry. 2008;79:1190–3. https://doi.org/10.1136/jnnp.2007.136440.

Article  CAS  PubMed  Google Scholar 

Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33:1444–52. https://doi.org/10.1212/wnl.33.11.1444.

Article  CAS  PubMed  Google Scholar 

Fisniku LK, Brex PA, Altmann DR, Miszkiel KA, Benton CE, Lanyon R, et al. Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis. Brain. 2008;131:808–17. https://doi.org/10.1093/brain/awm329.

Article  CAS  PubMed  Google Scholar 

Kilsdonk ID, Lopez-Soriano A, Kuijer JPA, Graaf WLD, Castelijns JA, Polman CH, et al. Morphological features of MS lesions on FLAIR at 7 T and their relation to patient characteristics. J Neurol Dr Dietrich Steinkopff Verlag GmbH Co KG. 2014;261:1356–64. https://doi.org/10.1007/S00415-014-7351-6/FIGURES/6.

Article  Google Scholar 

Kuchling J, Ramien C, Bozin I, Dörr J, Harms L, Rosche B, et al. Identical lesion morphology in primary progressive and relapsing–remitting MS –an ultrahigh field MRI study. Mult Scler. Volume 20. London, England: SAGE PublicationsSage UK; 2014. pp. 1866–71. https://doi.org/10.1177/1352458514531084.

Book  Google Scholar 

Al-Louzi O, Letchuman V, Manukyan S, Beck ES, Roy S, Ohayon J, et al. Central Vein Sign Profile of Newly Developing Lesions in Multiple Sclerosis: A 3-Year Longitudinal Study. Neurol Neuroimmunol Neuroinflammation. 2022;9:e1120. https://doi.org/10.1212/NXI.0000000000001120.

Article  Google Scholar 

Tallantyre EC, Dixon JE, Donaldson I, Owens T, Morgan PS, Morris PG, et al. Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions. Neurology. 2011;76:534–9. https://doi.org/10.1212/WNL.0B013E31820B7630.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Landes-Chateau C, Levraut M, Okuda DT, Themelin A, Cohen M, Kantarci OH et al. The diagnostic value of the central vein sign in radiologically isolated syndrome. Ann Clin Transl Neurol. John Wiley & Sons, Ltd; 2024;11:662–72. https://doi.org/10.1002/ACN3.51986

Sinnecker T, Clarke MA, Meier D, Enzinger C, Calabrese M, De Stefano N, et al. Evaluation of the Central Vein Sign as a Diagnostic Imaging Biomarker in Multiple Sclerosis. JAMA Neurol. 2019;76:1446–56. https://doi.org/10.1001/jamaneurol.2019.2478.

Article  PubMed  PubMed Central  Google Scholar 

Daboul L, O’Donnell CM, Amin M, Rodrigues P, Derbyshire J, Azevedo C, et al. A multicenter pilot study evaluating simplified central vein assessment for the diagnosis of multiple sclerosis. Mult Scler J. 2024;30:25–34. https://doi.org/10.1177/13524585231214360.

Article  CAS  Google Scholar 

Sati P, Oh J, Constable RT, Evangelou N, Guttmann CRG, Henry RG, et al. The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. Nat Rev Neurol. 2016;12:714–22. https://doi.org/10.1038/nrneurol.2016.166.

Article  PubMed  Google Scholar 

Cortese R, Magnollay L, Tur C, Abdel-Aziz K, Jacob A, Angelis FD, et al. Value of the central vein sign at 3T to differentiate MS from seropositive NMOSD. Neurol Lippincott Williams Wilkins. 2018;90:e1183–90. https://doi.org/10.1212/WNL.0000000000005256.

Article  Google Scholar 

Maggi P, Absinta M, Grammatico M, Vuolo L, Emmi G, Carlucci G et al. Central vein sign differentiates Multiple Sclerosis from central nervous system inflammatory vasculopathies. Ann Neurol. John Wiley & Sons, Ltd; 2018;83:283–94. https://doi.org/10.1002/ANA.25146

Campion T, Smith RJP, Altmann DR, Brito GC, Turner BP, Evanson J, et al. FLAIR* to visualize veins in white matter lesions: A new tool for the diagnosis of multiple sclerosis? Eur Radiol. Volume 27. Springer; 2017. pp. 4257–63. https://doi.org/10.1007/S00330-017-4822-Z/FIGURES/4.

Mistry N, Abdel-Fahim R, Samaraweera A, Mougin O, Tallantyre E, Tench C, et al. Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions. MSJ. Volume 22. London, England: SAGE PublicationsSage UK; 2015. pp. 1289–96. https://doi.org/10.1177/1352458515616700.

Book